Oncomfort news

Oncomfort, the Belgian inventor of and leader in Digital Sedation - a new method for relieving patients’ pain and anxiety without medication - today announces the completion of a €10 million Series A funding round co-led by two prominent institutional investors: Debiopharm and Crédit Mutuel Innovation. Oncomfort plans to use this investment to further develop its innovative digital therapy solutions and accelerate its international expansion.

Major investm

Oncomfort and Mario Huyghe mutually agreed to terminate the collaboration based on differences in view on the company’s strategy implementation.  Under the leadership of Mario, the Company has introduced Digital Sedation™ and a strong pipeline of innovations that entail the potential to make quantified Digital Sedation™ a true clinical breakthrough. We also introduced structures and processes of a real medical device company and strengthened the company with its o

Oncomfort, the leader in Digital Sedation^TM for relieving patients’ pain and anxiety without medication, is pleased to announce the appointment of Karl Schweitzer as non-executive Director and Chairman of the Board. With this appointment, Oncomfort brings on board the experienced leadership to guide the organisation in its global expansion and significant knowledge for the realization of the company’s strategy in Digital Sedation™

ONCOMFORT, GIGA CONSCIOUSNESS, ISIA LAB AND PILIPILI LAUNCH A CO-CREATION PROJECT WITH SUPPORT OF THE BIOWIN HEALTH CLUSTER FRAMEWORK 

The project aims at objectivizing Digital Sedation™, paving the way for the first management system for non-pharmacological sedation for use in daily clinical practice. 

In 2017, Oncomfort created a medical device for Digital Sedation™,

Oncomfort has won the Deloitte’s 2021 award for Most Disruptive Innovator.  This award is part of the Rising Star selection in the Deloitte Technology Fast 50 competition and is designed for promising companies that have been active in the technology sector for less than four years. The announcement was made at the Technology Fast 50 Awards Ceremony on 25 November 2021.

ncomfort, the leader in Digital Sedation™, a digital therapy to relieve patient anxiety and pain, today announces that it has obtained the ISO 13485:2016  certification by certification company DARE!! Services. This certification confirms that Oncomfort manages the design, manufacturing and distribution of its Digital

Oncomfort has just launched SILVA, a new module that enriches its library of solutions for the treatment of anxiety and pain for patients undergoing a medical procedure.

SILVA, which features a walk in the forest, is aimed at inducing a state of dissociation comparable to moderate or deep sedation, and is particularly suitable for populations suffering from respiratory disorders. SILVA uses a wide range of psychophysiological techniques which provide a significant anxiolytic impa

Oncomfort, the Belgian inventor of Digital Sedation^TM  - a new method for relieving patients’ pain and anxiety without medication –, and Vygon, global group specializing in single-use medical devices, today announce their commercial partnership in six European countries. The strong synergy between Vygon`s specialization and Oncomfort`s fields of application will enable greater acceleration of the adoption of Digital Sedation